Trial record 2 of 4 for:
"Erythroplakia"
Natural History of Oro-pharyngeal Cancer Precursors
This study has been completed.
Sponsor:
Albert Einstein College of Medicine, Inc.
Information provided by (Responsible Party):
Albert Einstein College of Medicine, Inc.
ClinicalTrials.gov Identifier:
NCT00179361
First received: September 13, 2005
Last updated: January 22, 2017
Last verified: November 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Oro-pharyngeal cancers can develop from squamous dysplastic precursor lesions, which occur in a subset of common white (leukoplakia), red (erythroplasia), or mixed oro-pharyngeal plaques. Known risk factors for oro-pharyngeal cancer include tobacco smoke, alcohol consumption, diet and, in a subset of tumors, human papillomavirus (HPV). Along the oro-pharyngeal disease continuum, there may be variations in gene expression precursor lesions as a result of exposure to smoking, alcohol and HPV. However, the components of gene expression that are most likely associated with tumorigenesis in these tissues are poorly understood. This study will focus upon early gene expression profiles in the oral cavity and oropharynx in subjects who have precursor lesions and have been exposed to the common risk factors for carcinoma development including smoking and HPV infection. This application is to conduct pilot testing and establish appropriate procedures for an international prospective cohort study of the natural history of oro-pharyngeal cancer precursors among men and women at high risk of oro-pharyngeal cancer at Montefiore Medical Center, Bronx-NY. Brush biopsy specimens will be used to collect a transepithelial sample of cells from oro-pharyngeal plaques, as well as normal tissue from defined regions of the oral and pharyngeal mucosa. Measurement of gene expression will employ novel high-throughput cDNA microarray analysis and PCR-based HPV DNA testing. Oro-pharyngeal dysplasia will be diagnosed using cytopathology. Under this application, we will assess our planned instruments and procedures on an initial sample of 40 subjects. This planning period will allow for precise identification of methodologies, standardization of instruments and assays to be utilized by additional participating centers in a subsequent application.
| Condition |
|---|
| Precancerous Conditions Leukoplakia Erythroplasia Oral Papillomas |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Natural History of Oral Cancer Precursors |
Resource links provided by NLM:
Genetic and Rare Diseases Information Center resources:
Oral Cancer
Lip and Oral Cavity Cancer
Leukoplakia
Erythroplakia
U.S. FDA Resources
Further study details as provided by Albert Einstein College of Medicine, Inc.:
Eligibility| Ages Eligible for Study: | 21 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Primary care Dental and Otolaryngology clinics.
Criteria
Inclusion Criteria:
- Established residence in the greater Metropolitan area of New York City, including Westchester, Long Island, Southern Connecticut and Northern New Jersey
Exclusion Criteria:
- No history of therapy for oral cancer in the previous 6 months
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00179361
Please refer to this study by its ClinicalTrials.gov identifier: NCT00179361
Locations
| United States, New York | |
| Montefiore Medical Center | |
| Bronx, New York, United States, 10467 | |
Sponsors and Collaborators
Albert Einstein College of Medicine, Inc.
Investigators
| Principal Investigator: | Nicolas F Schlecht, PhD | Albert Einstein College of Medicine, Inc. |
More Information
Publications:
| Responsible Party: | Albert Einstein College of Medicine, Inc. |
| ClinicalTrials.gov Identifier: | NCT00179361 History of Changes |
| Other Study ID Numbers: |
2003 -434 -000 DE016089-01 |
| Study First Received: | September 13, 2005 |
| Last Updated: | January 22, 2017 |
Additional relevant MeSH terms:
|
Papilloma Precancerous Conditions Leukoplakia Erythroplasia Neoplasms, Squamous Cell |
Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Pathological Conditions, Anatomical |
ClinicalTrials.gov processed this record on July 13, 2017


IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
